Literature DB >> 10480461

Pharmacokinetics of enrofloxacin given by the oral, intravenous and intramuscular routes in broiler chickens.

K Bugyei1, W D Black, S McEwen.   

Abstract

Enrofloxacin was given to broiler chickens, 3 groups of 6 birds each, at a dose of 5 mg/kg. Routes of administration were intravenous (i.v.), intramuscular (i.m.) and oral (p.o.) and blood samples were collected from the jugular vein for determination of serum drug levels over a 54-hour period after administration. Drug levels were determined using Bacillus subtilis spore suspension on Meuller-Hinton antibiotic medium. Intravenous administration produced drug levels which followed a bi-exponential decay according to the model C = 101e(-1.84(t)) + 1.30e(-0.06(t)). After i.m. administration, the mean Cmax observed (2.01 microg/mL) occurred at 1 h and levels were detected for up to 48 h. The mean time to maximum concentration (Tmax) for the birds occurred at 0.79 h. The model describing serum concentrations after i.m. administration was C = 1.35e(-0.48(t)) + 1.27e(-0.07(t)) - 2.06e(-2.1(t)). Serum concentrations after oral administration were lower and the mean +/- standard error of mean, of the maximum concentrations (Cmax) was 0.99 microg/mL at 2 h after administration. The mean residence times after the 3 routes of administration were not significantly different and ranged from 12.5-13.7 h. Bioavailability by the oral route was 80.1%. Dialysis of chicken plasma vs saline indicated that the protein binding was 22.7%.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480461      PMCID: PMC1189547     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  22 in total

1.  Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits.

Authors:  A Cabanes; M Arboix; J M Garcia Anton; F Reig
Journal:  Am J Vet Res       Date:  1992-11       Impact factor: 1.156

2.  1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

Authors:  G Y LESHER; E J FROELICH; M D GRUETT; J H BAILEY; R P BRUNDAGE
Journal:  J Med Pharm Chem       Date:  1962-09

3.  Distribution and excretion of four tetracycline analogues in normal young men.

Authors:  C M KUNIN; A C DORNBUSH; M FINLAND
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

4.  Pharmacokinetics of ciprofloxacin following intravenous and oral administration in broiler chickens.

Authors:  A H Atta; L Sharif
Journal:  J Vet Pharmacol Ther       Date:  1997-08       Impact factor: 1.786

5.  Pharmacokinetics and residues of enrofloxacin in chickens.

Authors:  A Anadón; M R Martínez-Larrañaga; M J Díaz; P Bringas; M A Martínez; M L Fernàndez-Cruz; M C Fernández; R Fernández
Journal:  Am J Vet Res       Date:  1995-04       Impact factor: 1.156

6.  Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows.

Authors:  L Kaartinen; M Salonen; L Alli; S Pyörälä
Journal:  J Vet Pharmacol Ther       Date:  1995-10       Impact factor: 1.786

7.  Pharmacokinetics of ciprofloxacin in ponies.

Authors:  P M Dowling; R C Wilson; J W Tyler; S H Duran
Journal:  J Vet Pharmacol Ther       Date:  1995-02       Impact factor: 1.786

8.  Quinolone resistance in veterinary isolates of Salmonella.

Authors:  D J Griggs; M C Hall; Y F Jin; L J Piddock
Journal:  J Antimicrob Chemother       Date:  1994-06       Impact factor: 5.790

9.  Pharmacokinetics of norfloxacin and its N-desethyl- and oxo-metabolites in broiler chickens.

Authors:  A Anadón; M R Martinez-Larrañaga; C Velez; M J Díaz; P Bringas
Journal:  Am J Vet Res       Date:  1992-11       Impact factor: 1.156

10.  Increase of ciprofloxacin resistance in Campylobacter species in Styria, Austria.

Authors:  G Feierl; A Pschaid; B Sixl; E Marth
Journal:  Zentralbl Bakteriol       Date:  1994-11
View more
  10 in total

1.  Pharmacokinetics of pefloxacin in goats after intravenous or oral administration.

Authors:  J K Malik; G S Rao; S Ramesh; S Muruganandan; H C Tripathi; D C Shukla
Journal:  Vet Res Commun       Date:  2002-02       Impact factor: 2.459

2.  Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in male and female turkeys following intravenous and oral administration.

Authors:  D J Dimitrova; L D Lashev; St G Yanev; V T Pandova
Journal:  Vet Res Commun       Date:  2006-05       Impact factor: 2.459

3.  Effect of administration route and dose escalation on plasma and intestinal concentrations of enrofloxacin and ciprofloxacin in broiler chickens.

Authors:  Mathias Devreese; Gunther Antonissen; Siegrid De Baere; Patrick De Backer; Siska Croubels
Journal:  BMC Vet Res       Date:  2014-12-02       Impact factor: 2.741

4.  Evaluation of the Presence and Levels of Enrofloxacin, Ciprofloxacin, Sulfaquinoxaline and Oxytetracycline in Broiler Chickens after Drug Administration.

Authors:  Débora Cristina Sampaio de Assis; Guilherme Resende da Silva; Isabela Pereira Lanza; Ana Cláudia Dos Santos Rossi Ribeiro; Ângela Maria Quintão Lana; Leonardo José Camargos Lara; Tadeu Chaves de Figueiredo; Silvana de Vasconcelos Cançado
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

5.  Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica).

Authors:  Antje Römer; Gesine Scherz; Saskia Reupke; Jessica Meißner; Jürgen Wallmann; Manfred Kietzmann; Heike Kaspar
Journal:  BMC Vet Res       Date:  2017-12-04       Impact factor: 2.741

6.  Pharmacokinetics, Pharmacodynamic Efficacy Prediction Indexes and Monte Carlo Simulations of Enrofloxacin Hydrochloride Against Bacterial Strains That Induce Common Clinical Diseases in Broiler Chickens.

Authors:  Karina P D Bonassa; Miwa Y Miragliotta; Rosineide C Simas; Marcos N Eberlin; Arturo Anadón; Ronilson A Moreno; Felix G R Reyes
Journal:  Front Vet Sci       Date:  2021-01-07

7.  Enrofloxacin Dose Optimization for the Treatment of Colibacillosis in Broiler Chickens Using a Drinking Behaviour Pharmacokinetic Model.

Authors:  Robin Temmerman; Ludovic Pelligand; Wim Schelstraete; Gunther Antonissen; An Garmyn; Mathias Devreese
Journal:  Antibiotics (Basel)       Date:  2021-05-19

8.  E. coli infection modulates the pharmacokinetics of oral enrofloxacin by targeting P-glycoprotein in small intestine and CYP450 3A in liver and kidney of broilers.

Authors:  Mengjie Guo; Yong Sun; Yu Zhang; Shamsuddin Bughio; Xiaohua Dai; Weilong Ren; Liping Wang
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  Abcb1 in Pigs: Molecular cloning, tissues distribution, functional analysis, and its effect on pharmacokinetics of enrofloxacin.

Authors:  Tingting Guo; Jinhu Huang; Hongyu Zhang; Lingling Dong; Dawei Guo; Li Guo; Fang He; Zohaib Ahmed Bhutto; Liping Wang
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

10.  Pharmacokinetics and tissue residue of enrofloxacin in healthy, Eimeria-infected broiler chickens and those pre-treated with amprolium and toltrazuril.

Authors:  M Atef; H A El-Banna; H Y Elzorba; A M Soliman
Journal:  Int J Vet Sci Med       Date:  2020-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.